People

Mervyn Turner

Mervyn Turner, PhD, is a director of Amydis. He spent 27 years at Merck, including leadership of worldwide licensing and external research and service as its first Chief Strategy Officer, before retiring in 2011 and establishing MJ Turner Consulting. Mervyn Turner serves on Spinogenix’s board. He previously worked at Merck for 27 years, leading licensing and external research and serving as chief strategy officer before establishing an independent consultancy.